BTAI icon

BioXcel Therapeutics

94 hedge funds and large institutions have $167M invested in BioXcel Therapeutics in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.11M
Puts
$1.68M
Net Calls
Net Calls Change

Top Sellers

1 -$13.7M
2 -$1.94M
3 -$1.69M
4
Jane Street
Jane Street
New York
-$1.63M
5
GCM
Graham Capital Management
Connecticut
-$897K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$55.4M
2
$18.8M
3
$18.3M
4
$13.1M
5
$5.58M
6
$5.17M
7
$4.82M
8
$4.54M
9
$2.99M
10
$2.72M
11
$2.49M
12
$2.07M
13
$1.85M
14
$1.83M
15
$1.65M
16
$1.54M
17
$1.47M
18
$1.35M
19
$1.31M
20
$1.2M
21
$1.17M
22
$1.13M
23
$1.13M
24
$1.05M
25
$959K